Editor's Note
The Food & Drug Administration on September 6 posted Hospira, Inc’s recall of one lot of Bacteriostatic Water for Injection, USP, 30 mL, multi-dose vials, lot W20308.
The recall was initiated because of the potential for a lack of sterility assurance.
To date, Hospira has not received any reports of adverse events associated with this issue for this lot.
Read More >>The promise of quicker recovery and fewer complications from sedation,…
New York, New York (January 31, 2024)–Sonio today announced that…
The US Food and Drug Administration receives more than 100,000…